-
4-(4-{[(2R,3R)-3-[(3-carbamimidoylphenyl)methyl]-4-methoxy-4-oxobutan-2-yl]carbamoyl}phenyl)pyridin-1-ium-1-olate
-
ChemBase ID:
175947
-
Molecular Formular:
C25H26N4O4
-
Molecular Mass:
446.49834
-
Monoisotopic Mass:
446.19540533
-
SMILES and InChIs
SMILES:
c1[n+](ccc(c1)c1ccc(cc1)C(=O)N[C@@H]([C@@H](Cc1cc(C(=N)N)ccc1)C(=O)OC)C)[O-]
Canonical SMILES:
COC(=O)[C@@H]([C@H](NC(=O)c1ccc(cc1)c1cc[n+](cc1)[O-])C)Cc1cccc(c1)C(=N)N
InChI:
InChI=1S/C25H26N4O4/c1-16(22(25(31)33-2)15-17-4-3-5-21(14-17)23(26)27)28-24(30)20-8-6-18(7-9-20)19-10-12-29(32)13-11-19/h3-14,16,22H,15H2,1-2H3,(H3,26,27)(H,28,30)/t16-,22-/m1/s1
InChIKey:
PFGVNLZDWRZPJW-OPAMFIHVSA-N
-
Cite this record
CBID:175947 http://www.chembase.cn/molecule-175947.html
NAMES AND DATABASE IDS
NAMES AND DATABASE IDS
Names Database IDs
IUPAC name
|
4-(4-{[(2R,3R)-3-[(3-carbamimidoylphenyl)methyl]-4-methoxy-4-oxobutan-2-yl]carbamoyl}phenyl)pyridin-1-ium-1-olate
|
|
|
IUPAC Traditional name
|
|
Synonyms
|
(αR)-3-(Aminoiminomethyl)-α-[(1R)-1-[[4-(1-oxido-4-pyridinyl)benzoyl]amino]ethyl]benzenepropanoic Acid Methyl Ester
|
[R-(R*,R*)]-3-(Aminoiminomethyl)-α-[1-[[4-(1-oxido-4-pyridinyl)benzoyl]amino]ethyl]benzenepropanoic Acid Methyl Ester
|
FXV 673
|
Methyl (2R,3R)-2-[3-Amidinobenzyl]-3-[[4-(1-oxido-4-pyridinyl)benzoyl]amino]butanoate
|
Otamixaban
|
|
|
CAS Number
|
|
PubChem SID
|
|
PubChem CID
|
|
DATA SOURCES
DATA SOURCES
All Sources Commercial Sources Non-commercial Sources
Data Source
|
Data ID
|
Price
|
TRC
|
|
CALCULATED PROPERTIES
CALCULATED PROPERTIES
JChem
Acid pKa
|
14.9449
|
H Acceptors
|
5
|
H Donor
|
3
|
LogD (pH = 5.5)
|
-0.879095
|
LogD (pH = 7.4)
|
-0.86946535
|
Log P
|
1.5362507
|
Molar Refractivity
|
137.6168 cm3
|
Polarizability
|
48.764984 Å3
|
Polar Surface Area
|
130.73 Å2
|
Rotatable Bonds
|
9
|
Lipinski's Rule of Five
|
true
|
PROPERTIES
PROPERTIES
Safety Information
Product Information
Bioassay(PubChem)
DETAILS
DETAILS
TRC
Toronto Research Chemicals -
O712500
|
A potent (Ki = 0.5 nM), selective, rapid acting, competitive and reversible fXa inhibitor that effectively inhibits both free and prothrombinase-bound fXa. Clinical studies show that it is efficacious, safe and well tolerated in humans and therefore has c |
PATENTS
PATENTS
PubChem Patent
Google Patent